Table 1 Anal cancer RR (95% CI) for HIV+ MSM and HIV+ non-MSM compared with HIV- controls (reference) and national US SEER rates.
From: Risk of anal cancer in HIV-infected patients and HIV-uninfected controls in North America
| RR (MSM) | RR (non-MSM) | SIR (MSM) | SIR (non-MSM) | |
|---|---|---|---|---|
| 1996 to 1998 | 97.7 (12.3-774.3) | 12.0 (0.7-195.5) | 63.5 (29.0-120.6) | 10.2 (0.3-56.9) |
| 1999 to 2002 | 114.7 (35.3-372.8) | 35.2 (9.8-126.5) | 117.3 (84.5-158.5) | 26.4 (11.4-52.0) |
| 2003 to 2007 | 48.1 (23.6-98.2) | 19.7 (8.8-44.1) | 77.7 (59.3-100.0) | 26.4 (14.8-43.5) |
